Angiotensin receptor blockers are lower incidence, progression of Alzheimer's disease

Researchers at Boston University School of Medicine (BUSM) have, for the first time, found that angiotensin receptor blockers (ARBs)—a particular class of anti-hypertensive medicines—are associated with a striking decrease in the occurrence and progression of dementia. Data from this study will be presented this weekend (July 27) at the 2008 International Conference on Alzheimer's disease in Chicago.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news136426165.html">Angiotensin receptor blockers are lower incidence, progression of Alzheimer's disease</a></p> <p>Researchers at Boston University School of Medicine (BUSM) have, for the first time, found that angiotensin receptor blockers (ARBs)—a particular class of anti-hypertensive medicines—are associated with a striking decrease in the occurrence and progression of dementia. Data from this study will be presented this weekend (July 27) at the 2008 International Conference on Alzheimer's disease in Chicago.</p>